Identification and optimisation of novel selective inhibitors against human regulator of G protein signalling 2 (RGS2) protein for type 2 diabetes mellitus: an in silico approach. - Goverdhan Lanka; Revanth Bathula; Mahendar Dasari; Manan Bhargavi; Sarita Rajender Potlapally (Int. J. Comput. Biol. Drug Des., 2021)

Pharmacophore-based virtual screening, 3D QSAR, Docking, ADMET, and MD simulation studies: An in silico perspective for the identification of new potential HDAC3 inhibitors. - Goverdhan Lanka; Darakhshan Begum; Suvankar Banerjee; Nilanjan Adhikari; Yogeeswari P; Balaram Ghosh (Comput. Biol. Medicine, 2023)